Friday, November 15, 2024
HomeTagsBiotechnology

Biotechnology

Rational Vaccines Announces a Clinical Study of the Frequency of Symptomatic Herpes Simplex Type 1 and 2 (HSV-1 and HSV-2) Virus in HIV Patients

Rational Vaccines, a company focused on revolutionizing the treatment and prevention of herpes to eradicate the disease, announced the launch of a clinical trial...

Synthetic Biologics Announces Planned Transformative Acquisition of VCN Biosciences; Developer of a Novel Oncolytic Virus Platform Targeting Pancreatic and other Solid Tumors

Synthetic Biologics, Inc., a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of high unmet need, announced it has signed a...

Lavie Bio Reports Advancement in its Bio-Fungicide Program for Fruit Rots

Lavie Bio Ltd., a leading ag-biologicals company focusing on improving food quality and agricultural productivity and sustainability through the introduction of microbiome-based products, and...

Alterity Therapeutics Announces First Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial

Alterity Therapeutics ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, announced that the New Zealand Medicines...

ImmunoGenesis Appoints Oncology Research Veteran to Lead Immuno-Oncology Clinical Development Targeting Immune-Excluded, “Cold” Cancers

ImmunoGenesis, a clinical-stage biotechnology company developing science-driven immune therapies, announced the appointment of seasoned industry veteran Charles Schweizer, PhD, as Senior Vice President of...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics